Hematological Oncology ▲ Sign in to save

• Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial

  2020 Hematological Oncology article Medicine Lymphoma Diagnosis and Treatment Open access

  Jan Rekowski, Stefan P Müller, Bernd Hertenstein, Christiane Franzius, Arnold Ganser, Frank Michael Bengel, +37 more

  28

  citations
• CONSOLIDATIVE HCT‐ASCT IS SUPERIOR TO NON‐MYELOABLATIVE CHEMO‐IMMUNOTHERAPY IN NEWLY‐DIAGNOSED PCNSL ‐ UPDATED RESULTS OF THE RANDOMIZED PHASE III MATRIX/IELSG43 TRIAL

  2023 Hematological Oncology article Medicine CNS Lymphoma Diagnosis and Treatment Open access

  Gerald Illerhaus, Andrés J.M. Ferreri, Mascha Binder, Peter Borchmann, Justin Hasenkamp, Stephan Stilgenbauer, +39 more

  7

  citations
• Capitalizing on paradoxical activation of the mitogen‐activated protein kinase pathway for treatment of Imatinib‐resistant mast cell leukemia

  2022 Hematological Oncology article Immunology and Microbiology Mast cells and histamine Open access

  Thomas Wilhelm, Marcelo A. S. Toledo, Ilka Simons, Christian Stuth, Vrinda Mohta, Ronja Isabelle Mülfarth, +9 more

  5

  citations
• EPCORITAMAB WITH RITUXIMAB + LENALIDOMIDE (R2) PROVIDES DURABLE RESPONSES IN HIGH‐RISK FOLLICULAR LYMPHOMA, REGARDLESS OF POD24 STATUS

  2023 Hematological Oncology article Medicine Lymphoma Diagnosis and Treatment Open access

  David Belada, Lorenzo Falchi, Sirpa Leppä, Joost S.P. Vermaat, Harald Holte, Martin Hutchings, +13 more

  5

  citations
• Identifying and addressing unmet clinical needs in primary cutaneous B‐cell lymphoma: A consensus‐based paper from an ad‐hoc international panel

  2023 Hematological Oncology article Medicine Cutaneous lymphoproliferative disorders research Open access

  Pietro Quaglino, Nicola Pimpinelli, Pier Luigi Zinzani, Marco Paulli, Stefano Aldo Pileri, Emilio Berti, +11 more

  2

  citations
• 465 | LOW RATES OF HIGH‐GRADE TOXICITIES WITH GLPG5101, A FRESH, STEM‐LIKE, EARLY MEMORY PHENOTYPE ANTI‐CD19 CAR T‐CELL THERAPY IN PATIENTS WITH NHL IN THE ATALANTA‐1 STUDY

  2025 Hematological Oncology article Medicine CAR-T cell therapy research Open access

  Joost S.P. Vermaat, Sébastien Anguille, Maria Theresa Kuipers, Pim G. N. J. Mutsaers, E. Willems, Michael Russell Bishop, +9 more

  1

  citations
• IMPACT OF RITUXIMAB ON TREATMENT OUTCOMES OF PATIENTS WITH ANGIOIMMUNOBLASTIC T‐CELL LYMPHOMA; A POPULATION‐BASED ANALYSIS

  2021 Hematological Oncology article Medicine Lymphoma Diagnosis and Treatment Open access

  Frederik O. Meeuwes, Mirian Brink, Marjolein van der Poel, Marie José Kersten, M. J. Wondergem, Pim G. N. J. Mutsaers, +7 more

  1

  citations
• EFFECTIVENESS AND SAFETY OF IBRUTINIB IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND MANTLE CELL LYMPHOMA (MCL) IN BELGIAN ROUTINE CLINICAL PRACTICE WITH A 3‐YEAR FOLLOW‐UP

  2021 Hematological Oncology article Medicine Chronic Lymphocytic Leukemia Research Open access

  Ann M. Janssens, Sylvia Snauwaert, Dominique Bron, Z. N. Berneman, Fritz C. Offner, Camille Van Bogaert, +5 more

  1

  citations
• Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies

  2022 Hematological Oncology article Medicine Chronic Myeloid Leukemia Treatments Open access

  Tariq I. Mughal, Naveen Pemmaraju, Rafael L. Bejar, Robert Peter Gale, Prithviraj Bose, Jean‐Jacques Kiladjian, +15 more

  0

  citations
• LACK OF SMARCB1 EXPRESSION CHARACTERIZES A SUBSET OF PERIPHERAL T‐CELL LYMPHOMAS ENRICHED IN CHILDREN AND YOUNG ADULTS

  2023 Hematological Oncology article Medicine Lymphoma Diagnosis and Treatment Open access

  A. Fischer, Natalia Moreno, Marta Interlandi, Thomas Albert, Jana Mormann, S. Glaser, +29 more

  0

  citations
• 275 | RADIOTHERAPY IN PATIENTS WITH ADVANCED STAGE MANTLE CELL LYMPHOMA ACHIEVES DURABLE LOCAL TUMOR CONTROL—A SAKK/GLA/EMCL REAL‐WORLD‐ANALYSIS FROM THE EMCL‐REGISTRY

  2025 Hematological Oncology article Medicine Lymphoma Diagnosis and Treatment Open access

  Sophia Drabke, Marie‐Kristin Tilch, Christiane Pott, María Gomes da Silva, Elisabeth Silkenstedt, Thomas Melchardt, +20 more

  0

  citations
• 327 | LONG‐TERM OUTCOME OF PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA ACHIEVING CR USING BISPECIFIC ANTIBODIES

  2025 Hematological Oncology article Medicine Lymphoma Diagnosis and Treatment Open access

  Evgenii Shumilov, Paolo Mazzeo, Joseph Kauer, Hristo Boyadzhiev, Niklas Gebauer, Udo Holtick, +46 more

  0

  citations
• 273 | REAL‐WORLD OUTCOMES OF PIRTOBRUTINIB IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: A MULTICENTER ANALYSIS WITH A CONTROL COHORT FROM THE EUROPEAN MCL REGISTRY

  2025 Hematological Oncology article Medicine Lymphoma Diagnosis and Treatment Open access

  Enver Aydilek, Friedrich Schwarz, L. Simon, Peter Dreger, Evgenii Shumilov, Georg Lenz, +25 more

  0

  citations
• Native E. coli asparaginase upfront should be replaced by PEGasparaginase upfront in the treatment of pediatric patients with acute lymphoblastic leukemia

  2021 Hematological Oncology article Medicine Acute Lymphoblastic Leukemia research

  Wing H. Tong, Montserrat Mesegué, José Luís Dapena, Mireia Camós, Susana Rives

  0

  citations
• Enteropathy associated T‐cell lymphoma: a population‐based cohort study on incidence, treatment and outcome in The Netherlands

  2023 Hematological Oncology article Medicine Lymphoma Diagnosis and Treatment Open access

  Frederik O. Meeuwes, Mirian Brink, Wouter J. Plattel, Joost S.P. Vermaat, Marie José Kersten, Mariëlle J. Wondergem, +7 more

  0

  citations
• R‐CODOX‐M/R‐IVAC VERSUS DA‐EPOCH‐R IN PATIENTS WITH NEWLY DIAGNOSED HIGH‐RISK BURKITT LYMPHOMA: FINAL RESULTS OF A MULTI‐CENTER RANDOMIZED HOVON/SAKK TRIAL

  2023 Hematological Oncology article Medicine Lymphoma Diagnosis and Treatment Open access

  Martine E.D. Chamuleau, Frank Stenner, Dana A. Chitu, Urban Novak, Monique C. Minnema, Otto J. Visser, +17 more

  0

  citations
• 611 | TUMOR EVOLUTION AND IMMUNE MICROENVIRONMENT DYNAMICS IN PRIMARY AND RELAPSED MANTLE CELL LYMPHOMA

  2025 Hematological Oncology article Medicine Lymphoma Diagnosis and Treatment Open access

  Hui Wan, Weicheng Ren, Mao Yang, Xiangchun Li, Agata Magdalena Wasik, Lei Du, +10 more

  0

  citations
• 462 | OUTCOMES AFTER CAR‐T CELL THERAPY (TISAGENLECLEUCEL OR AXICABTAGENE CILOLEUCEL) IN PATIENTS OLDER THAN 70 YEARS WITH DIFFUSE LARGE B CELL LYMPHOMA

  2025 Hematological Oncology article Medicine CAR-T cell therapy research Open access

  Vanderson Rocha, Jarl Mooyaart, Ron Ram, Katherine Clesham, Michael Daskalakis, Victoria T. Potter, +17 more

  0

  citations
• 102 | HIGH CR AND MRD NEGATIVITY RATES WITH GLPG5101, A FRESH, STEM‐LIKE, EARLY MEMORY CD19 CAR T WITH 7‐DAY VEIN‐TO‐VEIN TIME: FULL RESULTS FROM ATALANTA‐1 COHORT 3 (iNHL)

  2025 Hematological Oncology article Medicine CAR-T cell therapy research Open access

  Marie José Kersten, Maria Theresa Kuipers, Sébastien Anguille, E. Willems, Michael Russell Bishop, Tim J. A. Dekker, +12 more

  0

  citations
• 274 | REAL WORLD ANALYSIS: USE OF BREXUCABTAGENE AUTOLEUCEL FOR RELAPSED REFRACTORY MANTLE CELL LYMPHOMA OF ELDERLY PATIENTS (> 70 YEARS OLD)

  2025 Hematological Oncology article Medicine CAR-T cell therapy research Open access

  Nicole Santoro, Jarl Mooyaart, Michael Daskalakis, Goda Choi, Maeve A O'Reilly, Peter Dreger, +18 more

  0

  citations

20 results